Armistice Capital, LLC 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:34 pm Purchase |
2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 3,137,553 4.990% |
773,553 (+32.72%) |
Filing |
| 2024-11-14 4:51 pm Sale |
2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 2,364,000 5.960% |
-78,742 (-3.22%) |
Filing |
| 2024-02-14 3:35 pm Purchase |
2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 2,442,742 9.990% |
2,442,742 (New Position) |
Filing |